SCHEMBL3779634

SCHEMBL3779634

C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)Oc1cc(O)c2c(=O)c(O)c(-c3ccc(O)c(O)c3)oc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.64
▸ KMT2A Q03164 5/20 0.64
▸ KDM4E B2RXH2 3/20 0.64
▸ CYP3A4 P08684 3/20 0.64
▸ RECQL P46063 3/20 0.64
▸ HSD17B10 Q99714 3/20 0.64
▸ IPMK Q8NFU5 3/20 0.64
▸ IP6K2 Q9UHH9 3/20 0.64
▸ LMNA P02545 2/20 0.64
▸ APP P05067 2/20 0.64
▸ MAPT P10636 2/20 0.64
▸ THRB P10828 2/20 0.64
▸ AKR1B1 P15121 2/20 0.64
▸ ELAVL3 Q14576 2/20 0.64
▸ TDP1 Q9NUW8 2/20 0.64
▸ CYP1A2 P05177 4/20 0.57
▸ NOX4 Q9NPH5 3/20 0.57
▸ XDH P47989 3/20 0.57
▸ BCL9 O00512 3/20 0.57
▸ CTNNB1 P35222 3/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27781902 0.89 MEN1 (0.59) MEN1KMT2AKDM4ECYP3A4RECQL
SCHEMBL3789271 0.85 CYP1A2 (0.64) MEN1KMT2AKDM4ECYP3A4RECQL
SCHEMBL28482492 0.82 MEN1 (0.76) MEN1KMT2AKDM4ECYP3A4RECQL
SCHEMBL28322053 0.81 MEN1 (0.65) MEN1KMT2AKDM4ECYP3A4RECQL
SCHEMBL28574047 0.80 PLG (0.54) MEN1KMT2AKDM4ECYP3A4RECQL
SCHEMBL16309503 0.79 MEN1 (0.71) MEN1KMT2AKDM4ECYP3A4RECQL
SCHEMBL28948784 0.79 MEN1 (0.71) MEN1KMT2AKDM4ECYP3A4RECQL
Rhamnetin SCHEMBL555118 0.79 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4RECQL
Rhamnetin SCHEMBL29496169 0.79 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4RECQL
Rhamnetin SCHEMBL7164573 0.79 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3746006-B1 METHODS AND DEVICES FOR REDUCING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-06-26 — — EP disclosed
US-12011508-B2 Methods and devices for reducing vascular smooth muscle cell proliferation BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-06-18 — — US disclosed
EP-4359026-A1 COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) 2024-05-01 — — EP disclosed
WO-2022272243-A1 COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2022-12-29 — — WO disclosed
US-20210106728-A1 METHODS AND DEVICES FOR REDUCING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-04-15 — — US disclosed
EP-3746006-A1 METHODS AND DEVICES FOR REDUCING VACULAR SMOOTH MUSCLE CELL PROLIFERATION The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) 2020-12-09 — — EP disclosed
WO-2019152811-A1 METHODS AND DEVICES FOR REDUCING VACULAR SMOOTH MUSCLE CELL PROLIFERATION BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2019-08-08 — — WO disclosed
US-20150190253-A1 COATED DEVICES AND METHODS OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2015-07-09 — — US disclosed
US-8992471-B2 Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity NANOCOPOEIA, INC. (US) 2015-03-31 — — US disclosed
US-8992603-B2 Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity NANOCOPOEIA, INC. (US) 2015-03-31 — — US disclosed
US-20130030518-A1 COATED DEVICES AND METHOD OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER OFFICE OF RESEARCH (US) 2013-01-31 — — US disclosed
US-20100331965-A1 COATED DEVICES AND METHOD OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY NANOCOPOEIA, INC. (US) 2010-12-30 — — US disclosed
WO-2009061787-A1 COATED DEVICES AND METHOD OF MAKING COATED DEVICES THAT REDUCE SMOOTH MUSCLE CELL PROLIFERATION AND PLATELET ACTIVITY NANOCOPOEIA, INC. (US) 2009-05-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210106728-A1 METHODS AND DEVICES FOR REDUCING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION VCAM1, MYLK, TNNC1 MEN1 4691/4885KMT2A 3061/4885KDM4E 1350/4885
US-12011508-B2 Methods and devices for reducing vascular smooth muscle cell proliferation VCAM1, MYLK, TNNC1 MEN1 4691/4885KMT2A 3061/4885KDM4E 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback